Quantisnow Logo
Dashboard

Large owner Hill Path Capital Partners Lp was granted 2,024 shares (SEC Form 4)

$PRKS
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Get the next $PRKS alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hill Path Capital Partners LP
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
United Parks & Resorts Inc. [ PRKS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1)(2) 03/31/2025 A 2,024(3) A $0.00 83,587 I By Scott Ross
Common Stock(1)(2) 5,885,065 I By Hill Path Capital Partners LP(4)
Common Stock(1)(2) 176,201 I By Hill Path Capital Co-Investment Partners LP(5)
Common Stock(1)(2) 6,109,961 I By Hill Path Capital Partners Co-Investment E LP(6)
Common Stock(1)(2) 402,017 I By Hill Path Capital Partners Co-Investment E2 LP(7)
Common Stock(1)(2) 1,334,162 I By Hill Path Capital Partners-H LP(8)
Common Stock(1)(2) 83,900 I By Hill Path Capital Partners Co-Investment S LP(9)
Common Stock(1)(2) 10,518,006 I By HEP Fund LP(10)
Common Stock(1)(2) 2,695,994 I By HM Fund LP(11)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Hill Path Capital Partners LP
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Hill Path Capital Partners-H LP
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Hill Path Capital Co-Investment Partners LP
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Hill Path Capital Partners Co-Investment E LP
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Hill Path Capital Partners Co-Investment E2 LP
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Hill Path Capital Partners GP LLC
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Hill Path Capital Partners E GP LLC
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Hill Path Investment Holdings LLC
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Hill Path Capital LP
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
ROSS SCOTT I
(Last) (First) (Middle)
150 EAST 58TH STREET
33RD FLOOR
(Street)
NEW YORK NY 10155
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. This Form 4 is filed jointly by Hill Path Capital Partners LP ("Hill Path Capital"), Hill Path Co-Investment Partners LP ("Hill Path Co-Investment"), Hill Path Capital Partners-H LP ("Hill Path H"), Hill Path Capital Partners Co-Investment E LP ("Hill Path E"), Hill Path Capital Partners Co-Investment E2 LP ("Hill Path E2"), Hill Path Capital Partners Co-Investment S LP ("Hill Path S"), HEP Fund LP ("HEP Fund"), HM Fund LP ("HM Fund"), Hill Path Capital Partners GP LLC ("Hill Path GP"), Hill Path Capital Partners E GP LLC ("Hill Path E GP"), Hill Path Capital Partners S GP LLC ("Hill Path S GP"), HE GP LLC ("HE GP"), HM GP LLC ("HM GP"), Hill Path Investment Holdings LLC ("Hill Path Investment Holdings"), Hill Path Capital LP ("Hill Path"), Hill Path Holdings LLC ("Hill Path Holdings") and Scott Ross ("Mr. Ross," and collectively with the aforementioned entities, the "Reporting Persons").
2. To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same transactions being filed with the Securities and Exchange Commission. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group along with HAT Fund LP and HAT Fund II LP, which do not beneficially own any shares of Common Stock, that collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Mr. Ross is also a director of the Issuer. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
3. Granted under the Issuer's 2017 Omnibus Incentive Plan and vests 100% immediately.
4. Shares of Common Stock owned directly by Hill Path Capital. Hill Path GP, as the general partner of Hill Path Capital, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital. Hill Path Investment Holdings, as the managing member of Hill Path GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital. Hill Path, as the investment manager of Hill Path Capital, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Capital.
5. Shares of Common Stock owned directly by Hill Path Co-Investment. Hill Path GP, as the general partner of Hill Path Co-Investment, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment. Hill Path Investment Holdings, as the managing member of Hill Path GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment. Hill Path, as the investment manager of Hill Path Co-Investment, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path Co-Investment.
6. Shares of Common Stock owned directly by Hill Path E. Hill Path E GP, as the general partner of Hill Path E, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E. Hill Path Investment Holdings, as the managing member of Hill Path E GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E. Hill Path, as the investment manager of Hill Path E, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E.
7. Shares of Common Stock owned directly by Hill Path E2. Hill Path E GP, as the general partner of Hill Path E2, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2. Hill Path Investment Holdings, as the managing member of Hill Path E GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2. Hill Path, as the investment manager of Hill Path E2, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path E2.
8. Shares of Common Stock owned directly by Hill Path H. Hill Path GP, as the general partner of Hill Path H, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H. Hill Path Investment Holdings, as the managing member of Hill Path GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H. Hill Path, as the investment manager of Hill Path H, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path H.
9. Shares of Common Stock owned directly by Hill Path S. Hill Path S GP, as the general partner of Hill Path S, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S. Hill Path Investment Holdings, as the managing member of Hill Path S GP, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S. Hill Path, as the investment manager of Hill Path S, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S. Mr. Ross, as the managing partner of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by Hill Path S.
10. Shares of Common Stock owned directly by HEP Fund. HE GP, as the general partner of HEP Fund, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund. Hill Path Investment Holdings, as the managing member of HE GP, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund. Hill Path, as the investment manager of HEP Fund, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund. Mr. Ross, as the managing member of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by HEP Fund.
11. Shares of Common Stock owned directly by HM Fund. HM GP, as the general partner of HM Fund, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund. Hill Path Investment Holdings, as the managing member of HM GP, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund. Hill Path, as the investment manager of HM Fund, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund. Hill Path Holdings, as the general partner of Hill Path, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund. Mr. Ross, as the managing member of each of Hill Path Investment Holdings, Hill Path and Hill Path Holdings, may be deemed to beneficially own the shares of Common Stock owned directly by HM Fund.
Hill Path Capital Partners LP, By: Hill Path Capital Partners GP LLC, By: /s/ Scott Ross, Managing Partner 04/01/2025
Hill Path Capital Partners-H LP, By: Hill Path Capital Partners GP LLC, By: /s/ Scott Ross, Managing Partner 04/01/2025
Hill Path Capital Co-Investment Partners LP, By: Hill Path Capital Partners GP LLC, By: /s/ Scott Ross, Managing Partner 04/01/2025
Hill Path Capital Partners Co-Investment E LP, By: Hill Path Capital Partners E GP LLC, By: /s/ Scott Ross, Managing Partner 04/01/2025
Hill Path Capital Partners Co-Investment E2 LP, By: Hill Path Capital Partners E GP LLC, By: /s/ Scott Ross, Managing Partner 04/01/2025
Hill Path Capital Partners GP LLC, By: Hill Path Investment Holdings LLC, By: /s/ Scott Ross, Managing Partner 04/01/2025
Hill Path Capital Partners E GP LLC, By: Hill Path Investment Holdings LLC, By: /s/ Scott Ross, Managing Partner 04/01/2025
Hill Path Investment Holdings LLC, By: /s/ Scott Ross, Managing Partner 04/01/2025
Hill Path Capital LP, By: Hill Path Holdings LLC, By: /s/ Scott Ross, Managing Partner 04/01/2025
By: /s/ Scott Ross 04/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $PRKS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PRKS

DatePrice TargetRatingAnalyst
3/14/2025$50.00Equal Weight
Barclays
8/8/2024$63.00 → $53.00Buy → Neutral
Goldman
4/4/2024$73.00Buy
Guggenheim
3/26/2024$47.00Underperform
Mizuho
More analyst ratings

$PRKS
 Press Releases

Fastest customizable press release news feed in the world

See more

  • SeaWorld Orlando Reaches Historic Milestone with 1,000th Manatee Rescue, Reinforcing Decades of Dedication to Animal Rescue, Rehabilitation and Return

    DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., March 26, 2025 /PRNewswire/ -- SeaWorld Orlando has reached a historic milestone – 1,000 manatee rescues – marking a significant step in the ongoing fight to protect this vulnerable species. This achievement highlights SeaWorld's leadership in marine conservation, reinforcing its critical role in rescue, rehabilitation and return efforts. SeaWorld Orlando has spent nearly five decades committed to marine wildlife conservation and rescue. Since 1976, SeaWorld Orlando's dedicated rescue team has operated one of only three critical care f

    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

  • BABY SHARK MAKES A SPLASH AT SEAWORLD WITH EXCLUSIVE NEW LIVE CHARACTER EXPERIENCES AND ALL-NEW ANIMATED MUSIC VIDEO

    DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., March 20, 2025 /PRNewswire/ -- SeaWorld and The Pinkfong Company, the global entertainment company behind Baby Shark, are teaming up to celebrate 10 years of Baby Shark this year with exclusive live character interactions coming to SeaWorld parks, plus the world premiere of a brand-new animated music video, where Pinkfong and Baby Shark visit SeaWorld as veterinarians. Baby Shark and friends will be swimming from park to park, starting April 18 in SeaWorld San Diego before heading to SeaWorld Orlando for the summer on June 30 and then over to SeaWorld San Antonio for the fall starting September 11.

    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

  • SeaWorld San Diego Debuts a One-of-a-Kind Wonder: Jewels of the Sea - The Ultimate Jellyfish Experience!

    The largest standalone jellyfish exhibit in the country and a must-see in Southern California DOWNLOAD MEDIA ASSETS HERE SAN DIEGO, March 19, 2025 /PRNewswire/ -- SeaWorld San Diego is thrilled to unveil its highly anticipated Jewels of the Sea: The Jellyfish Experience, the largest standalone jellyfish exhibit in the country, is now open to the public. Starting today, visitors are invited to immerse themselves in the mesmerizing world of jellyfish, in this groundbreaking, first-of-its-kind attraction at SeaWorld Parks. Jewels of the Sea showcases the enchanting beauty, fasci

    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

$PRKS
 Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$PRKS
 Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$PRKS
 Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$PRKS
 SEC Filings

See more

$PRKS
 Leadership Updates

Live Leadership Updates

See more

  • SeaWorld Orlando Reaches Historic Milestone with 1,000th Manatee Rescue, Reinforcing Decades of Dedication to Animal Rescue, Rehabilitation and Return

    DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., March 26, 2025 /PRNewswire/ -- SeaWorld Orlando has reached a historic milestone – 1,000 manatee rescues – marking a significant step in the ongoing fight to protect this vulnerable species. This achievement highlights SeaWorld's leadership in marine conservation, reinforcing its critical role in rescue, rehabilitation and return efforts. SeaWorld Orlando has spent nearly five decades committed to marine wildlife conservation and rescue. Since 1976, SeaWorld Orlando's dedicated rescue team has operated one of only three critical care f

    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

  • Five Manatees Successfully Rehabilitated at Two Ohio Zoos Flown Back to Florida Facilities to Prepare for Return to Home Waters

    ORLANDO, Fla., Oct. 15, 2024 /PRNewswire/ -- Five manatees were flown more than 1,000 miles to their temporary homes in Florida, marking a crucial conservation achievement following over two years of successful rescue efforts by four zoological and marine institutions. In an intricate operation, the manatees were placed in custom-built containers to help them travel safely and then driven to the Cincinnati International Airport at the DHL Express Global hub. All of the manatees were loaded onto a specially scheduled DHL cargo plane to head to Florida, where they will complete

    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

  • United Parks & Resorts Inc. Appoints James Mikolaichik as Chief Financial Officer and Treasurer

    ORLANDO, Fla., Oct. 8, 2024 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE: PRKS), a leading theme park and entertainment company, today announced that James "Jim" Mikolaichik will assume the role of Chief Financial Officer (CFO) and Treasurer effective Nov. 11, 2024. Mr. Mikolaichik brings over 30 years of global financial and strategic planning experience to United Parks & Resorts. Throughout his career, he has overseen all aspects of financial business strategy, including planning, budgeting and forecasting, reporting, accounting, risk management, and corporate development, while driving business transformation and process improvements across organizations. Most recently, he served as

    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

$PRKS
 Financials

Live finance-specific insights

See more

  • United Parks & Resorts Inc. Reports Fourth Quarter and Fiscal 2024 Results

    ORLANDO, Fla., Feb. 26, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE:PRKS), a leading theme park and entertainment company, today reported its financial results for the fourth quarter and fiscal year 2024. Fourth Quarter 2024 Highlights Attendance was 4.9 million guests, a decrease of approximately 79,000 guests from the fourth quarter of 2023.Total revenue was $384.4 million, a decrease of $4.6 million or 1.2% from the fourth quarter of 2023.Net income was $27.9 million, a decrease of $12.2 million from the fourth quarter of 2023.Adjusted EBITDA[1] was $144.5 million a decrease of $6.0 million from the fourth quarter of 2023.Total revenue per capita[2] increased 0.4% to $78.75 fro

    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

  • UNITED PARKS & RESORTS INC. ANNOUNCES FOURTH QUARTER AND FISCAL 2024 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

    ORLANDO, Fla., Feb. 5, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE:PRKS) announced today that it will release its fourth quarter and fiscal 2024 financial results before the market opens on Wednesday, February 26, 2025. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, February 26, 2025, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.UnitedParksInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on February 26, 2025, under the "Events & Presen

    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

  • United Parks & Resorts Inc. Reports Third Quarter and First Nine Months 2024 Results

    ORLANDO, Fla., Nov. 7, 2024 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE:PRKS), a leading theme park and entertainment company, today reported its financial results for the third quarter and first nine months of fiscal year 2024. Third Quarter 2024 Highlights Attendance was 7.0 million guests, a decrease of approximately 0.1 million guests or 1.4% from the third quarter of 2023.Total revenue was $545.9 million, a decrease of $2.3 million or 0.4% from the third quarter of 2023.Net income was $119.7 million, a decrease of $3.9 million or 3.1% from the third quarter of 2023. Adjusted EBITDA[1] was $258.4 million, a decrease of $8.0 million or 3.0% from the third quarter of 2023. Total reve

    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

$PRKS
 Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more